These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5207 related articles for article (PubMed ID: 17587881)
1. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases. Orazi A Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881 [TBL] [Abstract][Full Text] [Related]
2. Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of bone marrow biopsies. Orazi A; Cattoretti G; Heerema NA; Sozzi G; John K; Neiman RS Mod Pathol; 1993 Sep; 6(5):521-5. PubMed ID: 8248107 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic problems in follow-up bone marrow biopsies of patients treated for acute and chronic leukaemias and MDS. Dirnhofer S; Went P; Tichelli A Pathobiology; 2007; 74(2):115-20. PubMed ID: 17587882 [TBL] [Abstract][Full Text] [Related]
4. [Panmyelopathy and myeloproliferative syndrome]. Jorke D; Bach G Z Gesamte Inn Med; 1986 Nov; 41(21):595-8. PubMed ID: 3469815 [TBL] [Abstract][Full Text] [Related]
5. Physician Education: Myelodysplastic Syndrome. Yoshida Y Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004 [TBL] [Abstract][Full Text] [Related]
6. Issues in the pathology of the myelodysplastic syndromes. Kampmeier P; Anastasi J; Vardiman JW Hematol Oncol Clin North Am; 1992 Jun; 6(3):501-22. PubMed ID: 1613003 [TBL] [Abstract][Full Text] [Related]
7. Acute panmyelosis with myelofibrosis: a clinicopathological study on 46 patients including histochemistry of bone marrow biopsies and follow-up. Thiele J; Kvasnicka HM; Zerhusen G; Vardiman J; Diehl V; Luebbert M; Schmitt-Graeff A Ann Hematol; 2004 Aug; 83(8):513-21. PubMed ID: 15173958 [TBL] [Abstract][Full Text] [Related]
8. p53 expression in myeloid cells of myelodysplastic syndromes. Association with evolution of overt leukemia. Kitagawa M; Yoshida S; Kuwata T; Tanizawa T; Kamiyama R Am J Pathol; 1994 Aug; 145(2):338-44. PubMed ID: 8053492 [TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes. Della Porta MG; Malcovati L; Boveri E; Travaglino E; Pietra D; Pascutto C; Passamonti F; Invernizzi R; Castello A; Magrini U; Lazzarino M; Cazzola M J Clin Oncol; 2009 Feb; 27(5):754-62. PubMed ID: 19103730 [TBL] [Abstract][Full Text] [Related]
10. Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool? Veltroni M; Sainati L; Zecca M; Fenu S; Tridello G; Testi AM; Merlone AD; Buldini B; Leszl A; Lo Nigro L; Longoni D; Bernini G; Basso G; Pediatr Blood Cancer; 2009 Mar; 52(3):357-63. PubMed ID: 19061215 [TBL] [Abstract][Full Text] [Related]
11. Differential diagnosis of myelofibrosis based on WHO 2008 criteria: acute panmyelosis with myelofibrosis, acute megakaryoblastic leukemia with myelofibrosis, primary myelofibrosis and myelodysplastic syndrome with myelofibrosis. Bae E; Park CJ; Cho YU; Seo EJ; Chi HS; Jang S; Lee KH; Lee JH; Lee JH; Suh JJ; Im HJ Int J Lab Hematol; 2013 Dec; 35(6):629-36. PubMed ID: 23693053 [TBL] [Abstract][Full Text] [Related]
12. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders. Hall J; Foucar K Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271 [TBL] [Abstract][Full Text] [Related]
13. [LAT (linker for activation of T cells): a useful marker for megakaryocyte evaluation on bone marrow biopsies]. Ungari M; Pellegrini W; Borlenghi E; Marocolo D; Ubiali A; Agazzi C; Pich A; Franco V; Facchetti F Pathologica; 2002 Dec; 94(6):325-30. PubMed ID: 12540999 [TBL] [Abstract][Full Text] [Related]
14. An autopsy case of myelodysplastic syndrome (MDS): diagnostic problems between MDS and the other haematopoietic disorders including acute myelofibrosis. Hayashi Y; Tange T; Chi LC; Ishida T; Kitamura T; Kitamura K; Urano Y Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):49-54. PubMed ID: 2741651 [TBL] [Abstract][Full Text] [Related]
15. [Histopathologic diagnosis of bone marrow in leukemia and related disorders]. Kikuchi M; Ohshima K; Kobari S Rinsho Byori; 1991 Dec; 39(12):1245-9. PubMed ID: 1779461 [TBL] [Abstract][Full Text] [Related]
16. Essential thrombocythemia with ringed sideroblasts: a heterogeneous spectrum of diseases, but not a distinct entity. Schmitt-Graeff A; Thiele J; Zuk I; Kvasnicka HM Haematologica; 2002 Apr; 87(4):392-9. PubMed ID: 11940483 [TBL] [Abstract][Full Text] [Related]
17. Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant. Singh ZN; Huo D; Anastasi J; Smith SM; Karrison T; Le Beau MM; Larson RA; Vardiman JW Am J Clin Pathol; 2007 Feb; 127(2):197-205. PubMed ID: 17210514 [TBL] [Abstract][Full Text] [Related]
19. The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms. Vardiman JW Chem Biol Interact; 2010 Mar; 184(1-2):16-20. PubMed ID: 19857474 [TBL] [Abstract][Full Text] [Related]
20. Histological and cytogenetic characterization of bone marrow in relation to prognosis and diagnosis of myelodysplastic syndromes. Sakuma T; Hayashi Y; Kanomata N; Murayama T; Matsui T; Kajimoto K; Hanioka K; Chihara K; Maeda S Pathol Int; 2006 Apr; 56(4):191-9. PubMed ID: 16634964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]